Philips proposes new appointment and re-appointments to its Supervisory Board and CEO re-appointment
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a ...
New laser shaft alignment solutions simplify alignment workflows, deliver measurable ROI, and introduce exclusive video replay technology to cut maintenance time and capture expertise Eindhoven, ...
CoaguSense, Inc., a leading developer of point-of-care coagulation monitoring systems and a subsidiary of i-SENS, Inc. (KOSDAQ: 099190), today announced it has entered into a definitive asset purchase ...
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has convened the Annual General Meeting of Shareholders (AGM) 2026 and published the agenda with ...
Anaveon, a late-stage preclinical biotech focused on reprogramming the immune system with precision biologics, announces today the appointment of Thaminda Ramanayake as its new Chief Executive Officer ...
Nexstim’s NBS System 6 gains FDA clearance for treatment of Obsessive Compulsive Disorder (OCD) Nexstim Plc ("Nexstim" o ...
ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore ...
Amphista Therapeutics (“the Company” or “Amphista”), a leader in the discovery and development of non-cereblon/non-VHL Targeted Glue™ degraders, today announces three upcoming presentations at the ...
On 23 March 2026, the portfolio managers of the GAM Global Opportunities Fund and the GAM Global Special Situations Fund published an open letter to John Ions, CEO of Liontrust Asset Management PLC ...
A new research project aims to develop the world’s first therapy to eliminate and prevent the spread of a toxic brain protein that drives Parkinson’s disease. Innovation Fund Denmark has invested DKK ...
New Rhapsido ® REMIX-1 & -2 pooled analysis on symptom control as early as week 1 in chronic spontaneous urticaria (CSU) to be presented; Long-term Cosentyx ® data build on exte ...
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results